Background-We reported that digoxin abolishes the infarct size (IS)-limiting effect of ischemic preconditioning (IPC).
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produces a marked resistance to subsequent prolonged episodes of ischemic stress in several mammalian species. [2] [3] [4] It is now recognized that ATP-sensitive K ϩ (K ATP ) channels are ubiquitous target effectors of the cardioprotective process by IPC, independent of species difference. [2] [3] [4] We have demonstrated in rabbit hearts that the prevention of ischemia-induced reduction of Na ϩ ,K ϩ -ATPase activity during the early phase of sustained ischemia contributes to the infarct size (IS)-limiting effect of IPC because pretreatment with digoxin, an inhibitor of Na ϩ ,K ϩ -ATPase, abolished the cardioprotective effect of IPC. 5 In guinea pig cardiac myocytes, 2 other cardiac glycosides, strophanthidin 6 and ouabain, 7 suppress the opening of K ATP channels by minimizing the consumption of subsarcolemmal ATP by Na ϩ ,K ϩ -ATPase. This notion led us to the hypothesis that the IS-limiting effect of IPC and the inhibitory action of digoxin reflect a functional interaction between Na ϩ ,K ϩ -ATPase and K ATP channels through the ATP concentration ([ATP]) in the subsarcolemmal compartment.
The purpose of the present study was to test this potential interaction. We compared the effect of digoxin on the IS limitation induced by IPC and that by a K ATP channel opener, cromakalim, in in vivo rabbit hearts, because it has been shown that K ATP channel openers evoke the opening of K ATP channels in the presence of relatively high concentrations of subsarcolemmal ATP. 8, 9 In addition, using patch-clamp techniques on single ventricular myocytes, we examined the effects of digoxin on K ATP channel activation.
Methods

Animal Preparation
Female Japanese white rabbits (2.5 to 3.2 kg) were anesthetized with 30 mg/kg sodium pentobarbital IV, intubated, then mechanically ventilated with 100% oxygen by use of a volume-cycled respirator. A fluid-filled catheter was placed in the right femoral artery and was connected to a transducer for measurement of arterial pressure. Ventilation was maintained at 15 to 20 breaths per minute with Ϸ40 mL of tidal volume. A left thoracotomy was performed in the fourth intercostal space, and the pericardium was opened. A 4-0 silk thread was then passed around the circumflex branch of the left coronary artery, with its ends being threaded through a small polyethylene tube. Precordial electrocardiography was monitored with bipolar chest leads. Rabbits were allowed Ն20 minutes to reach a steady state after surgical preparation. Coronary occlusion was produced by pulling the snare and clamping it with a mosquito hemostat. Reperfusion was produced by releasing the clamp.
Determination of IS
Animals were subjected to a 30-minute period of coronary artery occlusion followed by 3 hours of reperfusion. To achieve IPC, the coronary artery was occluded for 5 minutes, followed by 10 minutes of reperfusion, before the sustained occlusion and reperfusion. Rabbits were assigned randomly to 1 of 6 groups, including the control group, consisting of control animals given vehicle only; the IPC group, animals given vehicle before IPC; the digoxin group, animals given digoxin 0.3 mg/kg as a bolus injection 30 minutes before sustained ischemia; the digoxinϩIPC group, animals treated with digoxin before IPC; the cromakalim group, animals given cromakalim 4 g ⅐ kg Ϫ1 ⅐ min Ϫ1 over a period of 10 minutes as an intravenous infusion 10 minutes before sustained ischemia; and the digoxinϩcromakalim group, animals pretreated with digoxin 30 minutes before sustained ischemia before cromakalim treatment. The digoxin and digoxinϩIPC groups consisted of animals from our previous study. 5 In each protocol, the heart was rapidly excised at the end of the 3 hours of reperfusion and mounted by the aortic root on a Langendorff apparatus. The snare was retightened, and 0.5% phthalocyanine blue pigment was infused into the perfusate to demarcate the risk zone as the tissue without blue dye. The heart was then removed, and the left ventricle was isolated and cut into transverse slices 2 mm thick. The area at risk (nonblue area) was separated from each slice, weighed, and incubated at 37°C for 15 minutes in 1% triphenyl tetrazolium chloride (TTC) in phosphate buffer, pH 7.4. TTC stained the noninfarcted myocardium deep red. The sections were fixed in 10% formalin solution for Ͼ3 hours. Their digital images were then captured with a CCD camera and entered into an Apple Power Macintosh computer. The area at risk and the area of infarction (TTC-negative) were determined with image analysis software, corrected for the weight of each tissue slice, and summed for each heart. The IS was expressed as a percentage of the area at risk.
Single-Cell Preparation and Electrophysiology
Left ventricular myocytes were isolated from Japanese White rabbits by the collagenase perfusion method. Single ventricular myocytes were dispersed in a recording chamber (0.5 mL in volume) on the stage of an inverted microscope (Nikon, TMD-2) and were superfused with Tyrode's solution containing (in mmol/L) NaCl 143, NaH 2 PO 4 0.3, KCl 5.4, MgCl 2 0.5, CaCl 2 1.8, and HEPES/NaOH 5 (pH 7.4 adjusted by NaOH). For experiments using metabolic inhibition, single cells were preincubated with a glucose-free Kraft Brühe solution containing 2-deoxyglucose (5.5 mmol/L; Nacalai Tesque), an inhibitor of glycolysis, at 37°C for Ͼ30 minutes.
The pipette solution for K ATP current measurement contained (in mmol/L) aspartic acid 130, KCl 10, NaCl 10, MgCl 2 1.0, EGTA 10, and K 2 ATP 0.1 (pH 7.4 adjusted with HEPES/KOH 5). K ATP current was activated either by metabolic stress (glucose-and Ca 2ϩ -free Tyrode's solution containing 1 mmol/L NaCN) or by cromakalim (100 mol/L), recorded by ramp pulses applied every 10 seconds at Ϫ40-mV holding potential to obtain quasi-instantaneous current-voltage (I-V) relations. All the current data measured by an amplifier (List EPC-7) were directly displayed on a chart recorder (Graphtec, Linerecorder, WR 3320) with on-line acquisition to an NEC personal computer at a Bessel-type cutoff frequency of 1 kHz.
Single K ATP channel activity was recorded in either cell-attached, inside-out, or open cell-attached mode. Glucose-free Tyrode's solution was used as a pipette solution. To virtually eliminate the membrane potential, a K ϩ -rich solution was used as a bathing solution. Its composition was (in mmol/L) KCl 150, EGTA 0.5, and HEPES 5 (pH 7.4 adjusted by KOH). In the cell-attached mode, the K ATP channels were activated by metabolic inhibition (1 mmol/L NaCN, glucose-free) after incubation with 2-deoxyglucose (Ͼ20 minutes at 37°C) or by cromakalim (100 mol/L). The inhibition of the glycolysis pathway was applied to the myocytes only for metabolic stress-induced opening of the channel.
Brief (2 to 5 minutes) exposure of the myocytes to streptolysin O (0.02 to 0.08 U/mL, Nacalai Tesque) produced tiny holes on the cell membrane and allowed us to control the [ATP] just beneath the membrane by changing the [ATP] of the bathing solution. 7 The inside-out mode was achieved by excising the patch membrane into ATP-free bath solution. Patch pipettes were prepared by pulling borosilicate glass capillaries (Hilgenberg) at 2 to 3 M⍀ for wholecell and at 5 to 7.5 M⍀ for single-channel recordings when filled with pipette solution.
Data Analyses
The mean patch currents (I) for single-channel events were measured as the average difference between baseline (all channels closed) and open channel currents. The unitary amplitude (i) was estimated by the analysis of the amplitude distribution by use of pCLAMP software version 6.1 (Axon Instruments Inc) at a Bessel-type cutoff frequency of 100 Hz at a sample frequency of 1 kHz. The mean number of open channels (NP) was given by the product of the number of available channels in the patch (N) and the probability of their being open (P). NP was estimated by dividing the mean patch currents (IϭNPi) by unitary amplitude (i) as I/i.
Drugs
Digoxin (Sigma Chemical Co) was dissolved in distilled water at 1 mmol/L (stock solution) and glibenclamide (Sigma) in DMSO at 1 mmol/L (stock solution). Streptolysin O was dissolved in the bathing solution at a final concentration of 0.08 U/mL immediately before every experiment and was used within 3 to 4 hours after preparation. 7 All experiments were carried out at Ϸ36°C.
Statistical Analyses
The differences in time courses of hemodynamics change between groups, and time courses were analyzed by 2-way ANOVA with repeated measurements. In the IS study, the differences between groups were compared by 1-way ANOVA with Scheffé's post hoc test. A level of PϽ0.05 was accepted as statistically significant. In the electrophysiological study, statistical analyses were performed with an unpaired Student's t test. 
MAP indicates mean arterial pressure; HR, heart rate.
Results
Hemodynamics
The hemodynamic data are summarized in Table 1 . No significant differences were observed in mean arterial pressure or heart rate among the 6 groups at any of the experimentally determined time points.
Infarct Size
Data from the study of IS are summarized in Table 2 . Body weights, left ventricular weights, and area-at-risk weights did not differ significantly among any of the experimental groups. However, IS weights were significantly smaller in the IPC, cromakalim, and digoxinϩcromakalim groups than in the control group. Figure 1 shows the IS as a percentage of the area at risk in each experiment. IPC and cromakalim reduced the size of the infarct compared with control (11.8Ϯ1.8% and 13.4Ϯ2.6% versus 40.5Ϯ2.8%, respectively; PϽ0.05). The administration of 0.3 mg/kg digoxin had no effect on the IS compared with controls (39.8Ϯ5.0%) but significantly reduced the beneficial IS-limiting effects of IPC (33.5Ϯ3.3%). In contrast, it did not affect such effects induced by cromakalim (18.8Ϯ3.0%).
Effects of Digoxin on K ATP Channel Activities
Whole-Cell Experiments
Exposure of a myocyte preincubated with 2-deoxyglucose to glucose-and Ca 2ϩ -free Tyrode's solution containing 1 mmol/L NaCN activated outward conductance at a holding potential of Ϫ40 mV, usually within 10 minutes (Figure 2A) . Quasi-instantaneous I-V relationships ( Figure 2B-1) showed that the conductance induced by metabolic stress reversed at Ϫ83 mV and was inhibited by extracellular glibenclamide 1 mol/L) (Figure 2A, d and e) . Difference currents for metabolic stress-induced and glibenclamide-sensitive components (b-a in Figure 2C -1 and d-e in Figure 2C-3) showed reversal potentials of Ϫ85 mV, close to the estimated equilibrium potential for K ϩ (E K ) under these experimental conditions. These findings suggest that the current induced by metabolic inhibition is carried by the activation of K ATP channels.
External application of digoxin reversibly suppressed the conductance induced by metabolic stress (Figure 2A, b and c) without altering the reversal potential ( Figure 2B-2) . Current components sensitive to digoxin (b-c in Figure 2C -2) reversed at a potential of Ϫ82 mV, which is also close to E K . Similar findings were observed in 3 other experiments.
Percentage inhibitions of outward current at 0 mV were calculated as 100ϫ(b-c)/b as in Figures 2B and 2C-2 and were 89.6Ϯ3.3% (nϭ4). Thus, digoxin appeared to inhibit the K ATP channel current.
In the experiment shown in Figure 3A , cromakalim 100 mol/L evoked an outward current at a holding potential of Ϫ40 mV ( Figure 3A) . Because of the reversal potential (Ϫ83 mV; Figure 3A , a and b; 3B; and 3C-1) and block by glibenclamide ( Figure 3A, e and f) , the cromakalim-induced conductance was considered to be due to the activation of K ATP channels. Extracellular digoxin 1 and 10 mol/L did not significantly suppress the K ATP current induced by cromakalim ( Figure 3A, b and d; 3B; and 3C-2) . Failure of digoxin to inhibit the current was also observed in a total of 
Cell-Attached Experiments
The effect of digoxin on single K ATP channel activity was also examined in the cell-attached mode (Figure 4 ). K ATP channels were opened by either metabolic stress (A) or cromakalim 100 mol/L (B). K ATP channel currents were recorded as an upward deflection at 0 mV under these experimental conditions. Exposure of myocytes preincubated with 2-deoxyglucose 5.5 mmol/L to NaCN 1 mmol/L for 15 to 20 minutes produced the opening of single channels ( Figure 4A ), as did application of cromakalim into both pipette and external solutions ( Figure 4B ). Glibenclamide 0.5 mol/L inhibited both channel activities. Figure 4C summarizes the data obtained in both protocols at various concentrations of digoxin and glibenclamide 0.5 mol/L. Digoxin applied outside the pipette blocked the channel activities by metabolic inhibition in a reversible and concentration-dependent manner. In contrast, it had no effect on the channel activities evoked by cromakalim. Figure 5 shows the data obtained in inside-out (A) and open cell-attached modes (B and C). Excision of patch membrane into an ATP-free solution produced a robust opening of those single-channel currents that were sensitive to glibenclamide (1 mol/L; Figure 5A ). In the absence of internal ATP, the channels ran down gradually. The findings indicated that single-channel events were openings of K ATP channels. Digoxin 1 mol/L applied to the internal side of the patch membrane had no effect (only 5.5Ϯ2.5% inhibition of control).
Inside-Out and Open Cell-Attached Experiments
In the open cell-attached mode ( Figure 5B), we were able to open the channel by reducing extracellular [ATP] through tiny membrane holes made by streptolysin O. 7 In fact, raising extracellular ATP from 0 to 1 mmol/L reversibly closed the channel ( Figure 5B) . As in the experiments with cromakalim, digoxin 1 mol/L was without effect on the channel activity thus obtained. Figure 5C 
Discussion
Effects of Digoxin on IS in In Vivo Rabbit Hearts
We have previously demonstrated that pretreatment with digoxin, an inhibitor of Na ϩ ,K ϩ -ATPase, attenuated the K ATP channel-mediated IS-limiting effect of IPC in the rabbit heart. 5 Interestingly, however, we found in the present study that digoxin did fail to block the salutary IS-limiting effect of cromakalim. To explain this discrepancy, we focused on the interaction of Na ϩ ,K ϩ -ATPase and K ATP channels, because sarcolemmal molecules consuming subsarcolemmal ATP, such as Na ϩ ,K ϩ -ATPase, have been shown to alter the channel function through the change in subsarcolemmal [ATP]. 6, 7, 10, 11 The activation of K ATP channels is dependent on subsarcolemmal [ATP] during ischemia, 12, 13 whereas K ATP channel openers can open the channel in the presence of relatively high concentrations of ATP. 8, 9 It is therefore likely that an interaction between the Na ϩ ,K ϩ -ATPase and the channel via subsarcolemmal ATP would affect the ISlimiting action of IPC as well as its blockade by digoxin. This idea is not contradictory to the findings in previous studies 14, 15 using nuclear magnetic resonance spectroscopy 15 that myocardial [ATP] levels were relatively preserved in the preconditioned compared with nonpreconditioned hearts. This method cannot measure intracellular gradient of ATP because of the nonhomogeneous distribution of mitochondria, glycolysis-dependent ATP production, 10 or membrane molecule-induced consumption of ATP. 6, 7, 10, 11 During sustained ischemia, subsarcolemmal [ATP] could be low enough to activate K ATP channels in the preconditioned heart even though gross [ATP] remains relatively preserved, because the activities of sarcolemmal enzymes, especially Na ϩ ,K ϩ -ATPase, which consume subsarcolemmal ATP, are not attenuated during the early phase of sustained ischemia. 5 We used a single 5-minute IPC stimulus in the present study. It has been reported that bradykinin antagonists can block cardioprotection only when 1 cycle, but not 4 cycles, of IPC is used. 17 In contrast, we confirmed that digoxin inhibited even the IS-limiting effect induced by 3 cycles of IPC (data not shown). It appears that the IS-limiting effect by IPC requires Na ϩ ,K ϩ -ATPase activity to open K ATP channels.
Effects of Digoxin on K ATP Channel Activities in Isolated Rabbit Myocytes
In the present study, as in the findings in in vivo rabbit for myocardial ischemia, whole-cell experiments using patchclamp techniques demonstrated that digoxin reversibly inhibits the K ATP current induced by metabolic stress, but its inhibitory action was largely attenuated when the current was activated by cromakalim. In the cell-attached mode, digoxin also inhibited single K ATP channel currents activated by metabolic stress in a reversible and concentration-dependent manner, but not those activated by cromakalim. Therefore, the digoxin-induced inhibition of K ATP channels appeared to depend on subsarcolemmal [ATP] . This was also supported by the experimental finding that digoxin was without effect in the inside-out or open cell-attached modes. In the former, excision of patch membrane into an ATP-free solution produced opening of K ATP channels. The inhibition by digoxin was then negligible, indicating that the drug does not affect the channel directly. In the latter mode, through tiny membrane holes, subsarcolemmal [ATP] could be "concentration-clamped" at a desired level by [ATP] in the bathing extracellular solution. 7 Under these conditions, digoxin was also unable to inhibit the channel. The findings again suggest that Na ϩ ,K ϩ -ATPase and K ATP channel functionally interact through subsarcolemmal ATP.
We have previously reported that angiotensin II mediates the closure of K ATP channels through inhibition of adenylate cyclase, which transits from ATP to cAMP in guinea pig myocytes. 7 Conversely, Liu et al 18 showed that pretreatment with angiotensin II caused an IS-limiting effect in the rabbit heart. Angiotensin II potentially opens K ATP channels by stimulating protein kinase C activation, although the relationship between protein kinase C and K ATP channels still remains controversial. 19, 20 In angiotensin II-induced cardioprotection, this stimulatory pathway may act on K ATP channels more prominently over the inhibitory pathway via adenylate cyclase.
Cardioprotection by K ATP Channel Activation
In the present study, we assumed that both IPC-and cromakalim-mediated IS-limiting effects were derived from the activation of sarcolemmal K ATP channels. These beneficial effects have been thought to be due to the shortening of myocardial action potential duration (APD) and the subsequent reduction in Ca 2ϩ entry into myocytes. 12, 13 However, Yao and colleagues 21 demonstrated in dogs that bimakalim, a K ATP channel opener, conferred the IS-limiting effect at a dose that produced no shortening of APD. Likewise, Grover et al 22, 23 reported that the IS-limiting effects of cromakalim and IPC are preserved despite concomitant treatment with dofetilide, an antiarrhythmic agent with class III action, at a concentration sufficient to abolish the cromakalim-and IPCinduced shortening of APD.
Recently, mitochondrial K ATP channels have drawn considerable attention as targets for the action of K ATP channel openers. 24 Garlid et al 25 have shown that diazoxide, a potent mitochondrial but weak sarcolemmal K ATP channel opener, improves postischemic functional recovery and decreases lactate dehydrogenase release during reperfusion in isolated perfused rat and rabbit hearts subjected to global ischemia. However, the theory that mitochondrial K ATP channels alone contribute to the cardioprotection by IPC and K ATP channel openers cannot explain the dissociation of the inhibitory effects of digoxin on IS between IPC and cromakalim that we showed in this study. The potency of diazoxide to achieve cardioprotection was reported to be comparable to that of cromakalim in rabbit heart. 25 However, we found that diazoxide given in the same protocol as cromakalim did not induce any IS-limiting effect (IS, 33.4Ϯ5.9%, nϭ7) even at a 10-fold higher dose (40 g ⅐ kg Ϫ1 ⅐ min
Ϫ1
) than that of cromakalim used in the present study (4 g ⅐ kg Ϫ1 ⅐ min Ϫ1 ). Thus, sarcolemmal K ATP channels also play an important role in the IS-limiting effect of IPC and cromakalim in the in vivo rabbit model of regional myocardial ischemia. Because there was little relationship between APD shortening and cardioprotection in terms of K ATP channel openers, [21] [22] [23] further studies are necessary to examine the precise mechanism(s) underlying the K ATP channel-mediated cardioprotection.
